ZYXI 3-DAY DEADLINE ALERT: Investor Lawsuit Accuses Medical Device Maker Zynex (ZYXI) of Inflating Revenue Through Excessive Shipments; Subsequent Earnings Report Reveals Significant Financial Strain- Hagens Berman

Stock Information for Zynex Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Zynex Inc.

Zynex Financial Restructuring Puts Company on Path to Long-Term Success
Zynex Reports Third Quarter 2025 Financial Results
Zynex Announces Strategic Initiatives: Engagement of Province, Appointment of Paul Aronzon to Board of Directors, and Formation of Special Committee
Zynex Sets Third Quarter 2025 Earnings Call
Zynex Announces Appointment of Bret Wise to Board of Directors as Audit Committee Chair
ZYNEX INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Zynex, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
ZYNEX ALERT: Bragar Eagel & Squire, P.C. is Investigating Zynex, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Zynex Announces Arrival of Steven Dyson as CEO and Appointment of New Leadership in Key Roles

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.